$AGTC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in APPLIED GENETIC TECHNOLOGIES CORP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in APPLIED GENETIC TECHNOLOGIES CORP. Get notifications about new insider transactions in APPLIED GENETIC TECHNOLOGIES CORP for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 23 2015 | AGTC | APPLIED GENETIC TE ... | Washer Susan B. | President and CEO | Option Exercise | A | 18.48 | 80,000 | 1,478,400 | 80,000 | |
| Jul 23 2015 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Option Exercise | A | 18.48 | 51,000 | 942,480 | 51,000 | |
| Jul 23 2015 | AGTC | APPLIED GENETIC TE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Option Exercise | A | 18.48 | 37,000 | 683,760 | 37,000 | |
| Jul 23 2015 | AGTC | APPLIED GENETIC TE ... | Potter Stephen W | See Remarks | Option Exercise | A | 18.48 | 51,000 | 942,480 | 51,000 | |
| Jun 02 2015 | AGTC | APPLIED GENETIC TE ... | Shearman Mark S | Chief Scientific Of ... | Option Exercise | A | 19.50 | 110,000 | 2,145,000 | 110,000 | |
| Mar 20 2015 | AGTC | APPLIED GENETIC TE ... | PEACOCK BRUCE | Director | Option Exercise | A | 22.64 | 9,375 | 212,250 | 9,375 | |
| Feb 24 2015 | AGTC | APPLIED GENETIC TE ... | GLAXOSMITHKLINE PLC | Sell | S | 22.00 | 503,150 | 11,069,602 | 1,436,448 | 1.9 M to 1.4 M (-25.94 %) | |
| Feb 12 2015 | AGTC | APPLIED GENETIC TE ... | GLAXOSMITHKLINE PLC | 10% Owner | Sell | S | 21.01 | 12,000 | 252,136 | 1,939,598 | 2 M to 1.9 M (-0.61 %) |
| Feb 12 2015 | AGTC | APPLIED GENETIC TE ... | GLAXOSMITHKLINE PLC | 10% Owner | Sell | S | 21.00 | 8,000 | 168,000 | 1,951,598 | 2 M to 2 M (-0.41 %) |
| Feb 12 2015 | AGTC | APPLIED GENETIC TE ... | GLAXOSMITHKLINE PLC | 10% Owner | Sell | S | 21.24 | 7,500 | 159,294 | 1,959,598 | 2 M to 2 M (-0.38 %) |
| Feb 12 2015 | AGTC | APPLIED GENETIC TE ... | GLAXOSMITHKLINE PLC | 10% Owner | Sell | S | 21.28 | 12,500 | 266,035 | 1,967,098 | 2 M to 2 M (-0.63 %) |
| Feb 12 2015 | AGTC | APPLIED GENETIC TE ... | GLAXOSMITHKLINE PLC | 10% Owner | Sell | S | 21.18 | 10,000 | 211,760 | 1,979,598 | 2 M to 2 M (-0.50 %) |
| Feb 02 2015 | AGTC | APPLIED GENETIC TE ... | Potter Stephen W | VP and Chief Busine ... | Option Exercise | A | 24.62 | 131,049 | 3,226,426 | 131,049 | |
| Jan 26 2015 | AGTC | APPLIED GENETIC TE ... | Menichella Daniel L | V.P. & Chief Busine ... | Option Exercise | M | 4.90 | 1,996 | 9,780 | 115,972 | |
| Jan 26 2015 | AGTC | APPLIED GENETIC TE ... | Menichella Daniel L | V.P. & Chief Busine ... | Sell | S | 24.90 | 1,996 | 49,700 | 0 | 2 K to 0 (-100.00 %) |
| Jan 26 2015 | AGTC | APPLIED GENETIC TE ... | Menichella Daniel L | V.P. & Chief Busine ... | Buy | M | 4.90 | 1,996 | 9,780 | 1,996 | 0 to 2 K |
| Dec 23 2014 | AGTC | APPLIED GENETIC TE ... | Menichella Daniel L | V.P. & Chief Busine ... | Option Exercise | M | 4.90 | 9,000 | 44,100 | 117,968 | |
| Dec 23 2014 | AGTC | APPLIED GENETIC TE ... | Menichella Daniel L | V.P. & Chief Busine ... | Sell | S | 20.83 | 9,000 | 187,470 | 0 | 9 K to 0 (-100.00 %) |
| Dec 23 2014 | AGTC | APPLIED GENETIC TE ... | Menichella Daniel L | V.P. & Chief Busine ... | Buy | M | 4.90 | 9,000 | 44,100 | 9,000 | 0 to 9 K |
| Dec 23 2014 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | A | 20.83 | 4,688 | 97,651 | 4,688 | |
| Dec 23 2014 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Option Exercise | A | 20.83 | 4,688 | 97,651 | 4,688 | |
| Dec 23 2014 | AGTC | APPLIED GENETIC TE ... | Magovcevic Ivana | Director | Option Exercise | A | 20.83 | 4,688 | 97,651 | 4,688 | |
| Dec 23 2014 | AGTC | APPLIED GENETIC TE ... | Koenig Scott | Director | Option Exercise | A | 20.83 | 4,688 | 97,651 | 4,688 | |
| Dec 23 2014 | AGTC | APPLIED GENETIC TE ... | HURWITZ EDWARD | Director | Option Exercise | A | 20.83 | 4,688 | 97,651 | 4,688 | |
| Nov 19 2014 | AGTC | APPLIED GENETIC TE ... | Alta Partners VIII, L.P. | 10% Owner | Sell | J | 0.00 | 1,492,200 | 0 | 1,492,200 | 3 M to 1.5 M (-50.00 %) |
| Nov 19 2014 | AGTC | APPLIED GENETIC TE ... | HURWITZ EDWARD | Director | Buy | J | 0.00 | 1,800 | 0 | 1,800 | 0 to 1.8 K |
| Aug 04 2014 | AGTC | APPLIED GENETIC TE ... | Washer Susan B. | President & CEO | Option Exercise | A | 16.00 | 55,780 | 892,480 | 55,780 | |
| Aug 04 2014 | AGTC | APPLIED GENETIC TE ... | Knop David R. | Director, Process D ... | Option Exercise | A | 16.00 | 7,648 | 122,368 | 7,648 | |
| Aug 04 2014 | AGTC | APPLIED GENETIC TE ... | Chulay Jeffrey D. | V.P. & Chief Medica ... | Option Exercise | A | 16.00 | 23,250 | 372,000 | 23,250 | |
| Aug 04 2014 | AGTC | APPLIED GENETIC TE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Option Exercise | A | 16.00 | 60,799 | 972,784 | 60,799 | |
| Apr 21 2014 | AGTC | APPLIED GENETIC TE ... | Washer Susan B. | President & CEO | Option Exercise | A | 14.08 | 99,156 | 1,396,116 | 99,156 | |
| Apr 21 2014 | AGTC | APPLIED GENETIC TE ... | Menichella Daniel L | V.P. & Chief Busine ... | Option Exercise | A | 14.08 | 7,567 | 106,543 | 7,567 | |
| Apr 21 2014 | AGTC | APPLIED GENETIC TE ... | Knop David R. | Director, Process D ... | Option Exercise | A | 14.08 | 6,376 | 89,774 | 6,376 | |
| Apr 21 2014 | AGTC | APPLIED GENETIC TE ... | Chulay Jeffrey D. | V.P. & Chief Medica ... | Option Exercise | A | 14.08 | 19,230 | 270,758 | 19,230 | |
| Apr 02 2014 | AGTC | APPLIED GENETIC TE ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 15,671,969 | 0 | 0 | |
| Apr 02 2014 | AGTC | APPLIED GENETIC TE ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 32,707,070 | 0 | 0 | |
| Apr 02 2014 | AGTC | APPLIED GENETIC TE ... | GLAXOSMITHKLINE PLC | 10% Owner | Option Exercise | C | 0.00 | 17,625,289 | 0 | 0 | |
| Apr 02 2014 | AGTC | APPLIED GENETIC TE ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 12.00 | 103,762 | 1,245,144 | 1,989,598 | 1.9 M to 2 M (+5.50 %) |
| Apr 02 2014 | AGTC | APPLIED GENETIC TE ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | C | 0.00 | 1,885,836 | 0 | 1,885,836 | 0 to 1.9 M |
| Apr 21 2014 | AGTC | APPLIED GENETIC TE ... | BULLOCK LAWRENCE E | Chief Financial Off ... | Option Exercise | A | 14.08 | 2,502 | 35,228 | 2,502 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Wu Samuel | Director | Option Exercise | C | 4.54 | 11,896 | 54,008 | 11,896 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Wu Samuel | Director | Option Exercise | C | 0.13 | 416,361 | 54,002 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Wu Samuel | Director | Option Exercise | C | 0.00 | 5,699,111 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Wu Samuel | Director | Option Exercise | C | 0.00 | 11,893,926 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Wu Samuel | Director | Option Exercise | C | 0.00 | 6,409,436 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Wu Samuel | Director | Option Exercise | C | 0.00 | 11,478,652 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Wu Samuel | Director | Buy | P | 12.00 | 75,735 | 908,820 | 1,452,196 | 1.4 M to 1.5 M (+5.50 %) |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Wu Samuel | Director | Buy | C | 0.00 | 1,376,461 | 0 | 1,376,461 | 0 to 1.4 M |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | C | 4.54 | 8,920 | 40,497 | 8,920 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | C | 0.13 | 312,228 | 40,496 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | C | 0.00 | 4,273,746 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | C | 0.00 | 8,919,218 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | C | 0.00 | 4,806,416 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Option Exercise | C | 0.00 | 10,443,612 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Buy | P | 12.00 | 62,871 | 754,452 | 1,205,537 | 1.1 M to 1.2 M (+5.50 %) |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Rosen James | Director | Buy | C | 0.00 | 1,142,666 | 0 | 1,142,666 | 0 to 1.1 M |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Option Exercise | C | 4.54 | 11,895 | 54,003 | 11,895 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Option Exercise | C | 0.13 | 416,361 | 54,002 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Option Exercise | C | 0.00 | 5,699,111 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Option Exercise | C | 0.00 | 11,893,926 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Option Exercise | C | 0.00 | 6,409,436 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Option Exercise | C | 0.00 | 11,479,011 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Buy | P | 12.00 | 75,736 | 908,832 | 1,452,216 | 1.4 M to 1.5 M (+5.50 %) |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | ORONSKY ARNOLD L | Director | Buy | C | 0.00 | 1,376,480 | 0 | 1,376,480 | 0 to 1.4 M |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 4.54 | 11,896 | 54,008 | 11,896 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.13 | 416,361 | 54,002 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 5,699,111 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 11,893,926 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 6,409,436 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Option Exercise | C | 0.00 | 11,478,652 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Buy | P | 12.00 | 75,735 | 908,820 | 1,452,196 | 1.4 M to 1.5 M (+5.50 %) |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | MedImmune Ventures, Inc. | 10% Owner | Buy | C | 0.00 | 1,376,461 | 0 | 1,376,461 | 0 to 1.4 M |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Carroll Jill | Director | Option Exercise | C | 0.00 | 15,671,969 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Carroll Jill | Director | Option Exercise | C | 0.00 | 32,707,070 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Carroll Jill | Director | Option Exercise | C | 0.00 | 17,625,289 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Carroll Jill | Director | Buy | P | 12.00 | 103,762 | 1,245,144 | 1,989,598 | 1.9 M to 2 M (+5.50 %) |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Carroll Jill | Director | Buy | C | 0.00 | 1,885,836 | 0 | 1,885,836 | 0 to 1.9 M |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 23,507,953 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 49,060,606 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 26,437,934 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Alta Partners VIII, L.P. | 10% Owner | Buy | P | 12.00 | 155,645 | 1,867,740 | 2,984,400 | 2.8 M to 3 M (+5.50 %) |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | Alta Partners VIII, L.P. | 10% Owner | Buy | C | 0.00 | 2,828,755 | 0 | 2,828,755 | 0 to 2.8 M |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | INTERWEST PARTNERS VIII LP | 10% Owner | Option Exercise | C | 4.54 | 11,895 | 54,003 | 11,895 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | INTERWEST PARTNERS VIII LP | 10% Owner | Option Exercise | C | 0.13 | 416,361 | 54,002 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | INTERWEST PARTNERS VIII LP | 10% Owner | Option Exercise | C | 0.00 | 5,699,111 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | INTERWEST PARTNERS VIII LP | 10% Owner | Option Exercise | C | 0.00 | 11,893,926 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | INTERWEST PARTNERS VIII LP | 10% Owner | Option Exercise | C | 0.00 | 6,409,436 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | INTERWEST PARTNERS VIII LP | 10% Owner | Option Exercise | C | 0.00 | 11,479,011 | 0 | 0 | |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | INTERWEST PARTNERS VIII LP | 10% Owner | Buy | P | 12.00 | 75,376 | 904,512 | 1,452,216 | 1.4 M to 1.5 M (+5.47 %) |
| Apr 01 2014 | AGTC | APPLIED GENETIC TE ... | INTERWEST PARTNERS VIII LP | 10% Owner | Buy | C | 0.00 | 1,376,480 | 0 | 1,376,480 | 0 to 1.4 M |